Invention Grant
- Patent Title: Use of Favipiravir in treatment of coronavirus infection
-
Application No.: US17378361Application Date: 2021-07-16
-
Publication No.: US11318135B2Publication Date: 2022-05-03
- Inventor: Wu Zhong , Ruiyuan Cao , Cheng Cao , Ting Gao , Gengfu Xiao , Zhihong Hu , Manli Wang , Leike Zhang , Song Li
- Applicant: Academy of Military Medical Sciences
- Applicant Address: CN Beijing
- Assignee: Academy of Military Medical Sciences
- Current Assignee: Academy of Military Medical Sciences
- Current Assignee Address: CN Beijing
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: CN202010070142.0 20200121
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; A61P31/14
Abstract:
The present application relates to a Favipiravir compound represented by Formula I, a geometric isomer, a pharmaceutically acceptable salt, a solvate and/or a hydrate thereof, and a pharmaceutical composition comprising the compound for treating a coronavirus infection.
Public/Granted literature
- US20210346376A1 USE OF FAVIPIRAVIR IN TREATMENT OF CORONAVIRUS INFECTION Public/Granted day:2021-11-11
Information query
